Everest Organics FY26 Results: Net profit turns positive at ₹554.65 lakh
- Net profit turned positive to ₹554.65 lakh in FY26, reversing a ₹129.03 lakh loss
- Revenue grew 23% YoY to ₹19,615.77 lakh driven by operational improvements
- PBDIT more than doubled to ₹2,105.72 lakh, indicating strong margin expansion
- Board retained earnings without recommending a dividend for FY26
- Statutory auditors raised concerns over TSPCB production capacity compliance

*this image is generated using AI for illustrative purposes only.
Everest Organics returned to profitability in FY26, reporting a net profit of ₹554.65 lakh against a net loss of ₹129.03 lakh in the previous year. The company also announced that its 33rd Annual General Meeting (AGM) will be held on September 30, 2026.
Revenue from operations grew 23% to ₹19,615.77 lakh, up from ₹15,947.90 lakh in FY25. This top-line expansion was accompanied by a significant improvement in operating efficiency, with profit before financial cost, depreciation, and tax (PBDIT) more than doubling to ₹2,105.72 lakh from ₹790.98 lakh.
Financial Performance
The turnaround in profitability was driven by higher revenue and improved cost absorption. While finance costs increased to ₹652.76 lakh from ₹518.99 lakh, the overall operational gains outweighed these expenses. Earnings per share (EPS) stood at ₹5.70 for the year.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue from Operations | ₹19,615.77 lakh | ₹15,947.90 lakh | +23% |
| Net Profit | ₹554.65 lakh | (₹129.03 lakh) | Turnaround |
| PBDIT | ₹2,105.72 lakh | ₹790.98 lakh | +166% |
| EPS | ₹5.70 | (₹2.97) | Positive |
What the Numbers Show
The divergence between revenue growth and margin expansion highlights improved operational leverage. Revenue rose by approximately ₹3,668 lakh, while total expenses grew by only ₹2,596 lakh. This indicates that the additional revenue generated contributed disproportionately to the bottom line, allowing the company to cover fixed costs more effectively and reverse the prior year's loss.
Governance and Regulatory Updates
The Board did not recommend a dividend for FY26, opting instead to retain earnings to strengthen the balance sheet. Reserves and surplus increased to ₹6,576.77 lakh.
The AGM agenda includes the ratification of remuneration for cost auditors and the appointment of three new independent directors: Mr. Venkata Ramana Narra, Mr. Srikanth Reddy Kolli, and Mr. Subroto Banerjee. Remote e-voting will be open from September 27 to September 29, 2026.
Auditor Qualifications
The statutory auditors issued a qualified opinion regarding environmental compliance. The Telangana State Pollution Control Board (TSPCB) has stipulated that the company cannot exceed its approved production capacity. Management stated that applications for Consent for Establishment (CFE) for enhanced capacities are pending approval, though an Environmental Clearance Certificate has been obtained.
Historical Stock Returns for Everest Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.81% | -2.17% | -10.52% | -12.52% | -31.95% | -17.38% |
How might the pending approval for Consent for Establishment (CFE) impact Everest Organics' ability to scale production and sustain its current revenue growth trajectory?
What specific operational strategies or cost-control measures are driving the significant improvement in PBDIT margins, and are these gains sustainable in the near term?
Given the decision to retain earnings rather than pay dividends, what is management's roadmap for utilizing these reserves to strengthen the balance sheet or fund future expansion?


































